FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160277103> ?p ?o ?g. }

• W2160277103 endingPage "586" @default.
• W2160277103 startingPage "574" @default.
• W2160277103 abstract "Article AbstractObjective: To establish the long-term effectiveness of 3 treatments for DSM-IV panic disorder with or without agoraphobia: cognitive-behavioral therapy (CBT), pharmacotherapy using a selective serotonin reuptake inhibitor (SSRI), or the combination of both (CBT + SSRI). As a secondary objective, the relationship between treatment outcome and 7 predictor variables was investigated. Method: Patients were enrolled between April 2001 and September 2003 and were randomly assigned to treatment. Academic and nonacademic clinical sites participated. Each treatment modality lasted 1 year. Pharmacotherapists were free to choose between 5 SSRIs currently marketed in The Netherlands. Outcome was assessed after 9 months of treatment (posttest 1), after discontinuation of treatment (posttest 2), and 6 and 12 months after treatment discontinuation (follow-up 1 and follow-up 2). Results: In the sample (N = 150), 48% did not suffer from agoraphobia or suffered from only mild agoraphobia, while 52% suffered from moderate or severe agoraphobia. Patients in each treatment group improved significantly from pretest to posttest 1 on the primary outcome measures of level of anxiety (P < .001), degree of coping (P < .001), and remitter status (P < .001), as well as on the secondary outcome measures of depressive symptomatology (P < .001), and from pretest to posttest 2 for health-related quality of life (P < .001). Gains were preserved from posttest 2 throughout the follow-up period. Some superiority of CBT + SSRI and SSRI as compared with CBT was observed at posttest 1. However, at both follow-ups, differences between treatment modalities proved nonsignificant. Client satisfaction appeared to be high at treatment endpoint, while patients receiving CBT + SSRI appeared slightly (P < .05) more satisfied than those receiving CBT only. Conclusions: No fall-off in gains was observed for either treatment modality after treatment discontinuation. SSRIs were associated with adverse events. Gains produced by CBT were slower to emerge than those produced by CBT + SSRI and SSRI, but CBT ended sooner. Trial Registration: Netherlands Trial Register (www.trialregister.nl) Identifier: ISRCTN8156869J Clin Psychiatry 2010;71(5):574-586Submitted: September 5, 2008; accepted April 20, 2009. Corresponding author: Franske J. van Apeldoorn, MSc, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands (f.j.van.apeldoorn@psy.umcg.nl)." @default.
• W2160277103 created "2016-06-24" @default.
• W2160277103 creator A5001504259 @default.
• W2160277103 creator A5025590620 @default.
• W2160277103 creator A5034229037 @default.
• W2160277103 creator A5037632552 @default.
• W2160277103 creator A5049001799 @default.
• W2160277103 creator A5073453632 @default.
• W2160277103 creator A5083344813 @default.
• W2160277103 date "2010-05-15" @default.
• W2160277103 modified "2023-10-13" @default.
• W2160277103 title "A Randomized Trial of Cognitive-Behavioral Therapy or Selective Serotonin Reuptake Inhibitor or Both Combined for Panic Disorder With or Without Agoraphobia" @default.
• W2160277103 cites W141350601 @default.
• W2160277103 cites W1573926714 @default.
• W2160277103 cites W1578600378 @default.
• W2160277103 cites W1816775564 @default.
• W2160277103 cites W1970952733 @default.
• W2160277103 cites W1971934524 @default.
• W2160277103 cites W1975151273 @default.
• W2160277103 cites W1980911127 @default.
• W2160277103 cites W1981721628 @default.
• W2160277103 cites W1983751518 @default.
• W2160277103 cites W1987017789 @default.
• W2160277103 cites W1990406703 @default.
• W2160277103 cites W1995051494 @default.
• W2160277103 cites W1995224881 @default.
• W2160277103 cites W1999522554 @default.
• W2160277103 cites W2016065484 @default.
• W2160277103 cites W2019284559 @default.
• W2160277103 cites W2020018978 @default.
• W2160277103 cites W2037061841 @default.
• W2160277103 cites W2045602057 @default.
• W2160277103 cites W2052460221 @default.
• W2160277103 cites W2054983745 @default.
• W2160277103 cites W2071501721 @default.
• W2160277103 cites W2071806474 @default.
• W2160277103 cites W2083336749 @default.
• W2160277103 cites W2090446436 @default.
• W2160277103 cites W2091397788 @default.
• W2160277103 cites W2106134761 @default.
• W2160277103 cites W2112336497 @default.
• W2160277103 cites W2114613490 @default.
• W2160277103 cites W2117146356 @default.
• W2160277103 cites W2129103455 @default.
• W2160277103 cites W2135917232 @default.
• W2160277103 cites W2148991048 @default.
• W2160277103 cites W2156254681 @default.
• W2160277103 cites W2160070901 @default.
• W2160277103 cites W2171662288 @default.
• W2160277103 cites W2413807254 @default.
• W2160277103 cites W33455727 @default.
• W2160277103 cites W2245231029 @default.
• W2160277103 doi "https://doi.org/10.4088/jcp.08m04681blu" @default.
• W2160277103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20492852" @default.
• W2160277103 hasPublicationYear "2010" @default.
• W2160277103 type Work @default.
• W2160277103 sameAs 2160277103 @default.
• W2160277103 citedByCount "29" @default.
• W2160277103 countsByYear W21602771032012 @default.
• W2160277103 countsByYear W21602771032013 @default.
• W2160277103 countsByYear W21602771032014 @default.
• W2160277103 countsByYear W21602771032015 @default.
• W2160277103 countsByYear W21602771032016 @default.
• W2160277103 countsByYear W21602771032017 @default.
• W2160277103 countsByYear W21602771032018 @default.
• W2160277103 countsByYear W21602771032019 @default.
• W2160277103 countsByYear W21602771032022 @default.
• W2160277103 crossrefType "journal-article" @default.
• W2160277103 hasAuthorship W2160277103A5001504259 @default.
• W2160277103 hasAuthorship W2160277103A5025590620 @default.
• W2160277103 hasAuthorship W2160277103A5034229037 @default.
• W2160277103 hasAuthorship W2160277103A5037632552 @default.
• W2160277103 hasAuthorship W2160277103A5049001799 @default.
• W2160277103 hasAuthorship W2160277103A5073453632 @default.
• W2160277103 hasAuthorship W2160277103A5083344813 @default.
• W2160277103 hasConcept C118552586 @default.
• W2160277103 hasConcept C126322002 @default.
• W2160277103 hasConcept C15744967 @default.
• W2160277103 hasConcept C168563851 @default.
• W2160277103 hasConcept C169900460 @default.
• W2160277103 hasConcept C2777529043 @default.
• W2160277103 hasConcept C2778678127 @default.
• W2160277103 hasConcept C2778715236 @default.
• W2160277103 hasConcept C2779177272 @default.
• W2160277103 hasConcept C2779477915 @default.
• W2160277103 hasConcept C2780051608 @default.
• W2160277103 hasConcept C2780092697 @default.
• W2160277103 hasConcept C2781265626 @default.
• W2160277103 hasConcept C558461103 @default.
• W2160277103 hasConcept C70410870 @default.
• W2160277103 hasConcept C71924100 @default.
• W2160277103 hasConceptScore W2160277103C118552586 @default.
• W2160277103 hasConceptScore W2160277103C126322002 @default.
• W2160277103 hasConceptScore W2160277103C15744967 @default.
• W2160277103 hasConceptScore W2160277103C168563851 @default.
• W2160277103 hasConceptScore W2160277103C169900460 @default.
• W2160277103 hasConceptScore W2160277103C2777529043 @default.
• W2160277103 hasConceptScore W2160277103C2778678127 @default.

• next